Search and review clinical trials. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.
The VIS Opti-K Low Vision Aid device will be used to provide vision improvement to patients with refractive disorders (hyperopia and presbyopia).
Male or Female [+13]
Corneal disease or corneal disorder in either eye. [+8]
The goal of this clinical trial is to evaluate the safety and efficacy of using the VIS Opti-K System to enable monovision by providing temporary improvement in near vision through the treatment of the non-dominant eye of low myopic, emmetropic and low hyperopic presbyope subjects. The main questions it aims to answer are determining uncorrected near visual acuity at 40cm in the treated eye and subjective improvement as measured by the patient satisfaction questionnaire.
Subject age is equal to or greater than 40 years old. [+12]
Latent hyperopia 1.0 D (i.e., baseline MRSE and CRSE should not differ by or be... [+18]
This study is being conducted to assess the safety and efficacy of the VIS, LLC (VIS) Opti-K Low Vision Aid Device and treatment to provide vision improvement to patients with age-related macular degeneration.
Male or Female [+10]
Corneal disease or corneal disorder in either eye. [+5]